Nanodiamond mediated molecular targeting in Pancreatic Ductal adenocarcinoma: Disrupting the tumor-stromal cross-talk, next hope on the horizon?

Nanodiamonds (NDs), due to their unique surface characteristics, have emerged as a promising nano delivery system in various pre-clinical cancer models and have the potential to deliver the chemotherapeutic payload by moving beyond the dynamic tumor-stromal barrier. It can be the next revolution in nanoparticle-mediated pancreatic cancer targeting.